Lymphoma

Natera Acquires Foresight Diagnostics in $450 Million Deal

Transaction expands Natera's solid tumor MRD capabilities and adds ultrasensitive phased variant technology with detection below 0.1 parts per million.

Lymphoma

Simple Blood Test Predicts Neurotoxic Complications of CAR-T Cell Therapy

CAR-T cell therapy has revolutionized the treatment of several cancers, using modified T cells to target types of leukemia & lymphoma.

Lymphoma

Interventional Study to Evaluate Multicancer Early Detection Test

The Pathfinder study will enroll 6,200 participants to evaluate Grail’s investigational multicancer early detection test in clinical practice.

From the Editor: New Ideas

May 7, 2019 | Lymphoma, Prostate

In a field where highly trained professionals interact on a daily basis with an ever-changing array of innovative technologies, new and useful ideas seem to be around every corner.

Clinical Flow Cytometry System Improves Workflow

May 6, 2019 | Flow Cytometry, Flow Cytometry Instruments, Lymphoma

New 10-color system with Kaluza C software streamlines workflow and QC reporting for flow cytometry in leukemia and lymphoma analysis.

January 2019 Product Spotlight: 2019 Emerging Technologies Showcase

Apr 14, 2019 | Breast, Cardiovascular, Culture Media, Lymphoma, Melanoma, Prostate, Slides

Nano-Signature Discovery Could Revolutionize Cancer Diagnosis A quick and easy test to...

Study Results Guide Anti-CMV Treatment after Stem Cell Transplantation

Feb 12, 2019 | Lymphoma, Research, Tuberculosis

Continued validation of Lophius’ development capabilities bodes well as the company advances into tuberculosis diagnostics as its next focus area.

Nano-Signature Discovery Could Revolutionize Cancer Diagnosis

Dec 20, 2018 | Lymphoma, Research

The new technology has proved to be up to 90% accurate in tests involving 200 human cancer samples and normal DNA.

Determining Molecular Response in Chronic Myeloid Leukemia

Nov 9, 2018 | Disease States, Leukemia, Lymphoma, Molecular Diagnostics

Droplet digital PCR can provide a more accurate assessment of low levels of BCR-ABL mRNA than quantitative real-time PCR.

ASCP, ASH, and CAP Invite Public Comment on Lymphoma Guideline

Sep 28, 2018 | Lymphoma

Multidisciplinary guidance document focuses on specimen requirements for the diagnosis of lymphoma.

August/September 2017 Product Spotlight: New Products Showcase

Aug 28, 2017 | Flow Cytometry, Flow Cytometry Instruments, Lymphoma, Microbiology Instruments, Molecular Diagnostics

This month’s Product Spotlight features new products from such companies as Advanced Instruments, Beckman Coulter, and Thermo Fisher Scientific.

HTG Molecular Diagnostics Launches NGS-Based Cell-of-Origin Assay for Diffuse Large B-Cell Lymphomas

Oct 19, 2015 | Lymphoma, Molecular Diagnostics

HTG’s next-generation sequencing assay enables subtyping of DLBCL as activated B-cell-like or germinal center B-cell-like.

NCI Awards $1.4 Million Grant to Advanced Cell Diagnostics

Oct 13, 2014 | Cancer, Lymphoma, Molecular Diagnostics, Research

Under a new grant from the National Cancer Institute, Advanced Cell Diagnostics will partner with the Cleveland Clinic to develop an ultrasensitive diagnostic test for B-cell lymphoma.

PathGroup Collaboration to Offer Genomic Profiling of Hematologic Malignancies

Mar 24, 2014 | Cancer, Leukemia, Lymphoma, Molecular Diagnostics

A new collaboration plans to provide genomic profiling and information for patients that have been unsuccessful on repeated therapy for the group of cancers that include leukemias, lymphomas, and myeloproliferative and myelodysplastic diseases.